관절내 점성 보충 시장 규모, 점유율, 성장 분석 : 제품별, 용도별, 소스별, 최종사용자별, 지역별 - 업계 예측(2025-2032년)

Global Viscosupplementation Market size was valued at USD 5.1 billion in 2024 and is poised to grow from USD 5.38 billion in 2025 to USD 8.26 billion by 2033, growing at a CAGR of 5.5% during the forecast period (2026-2033).

The global viscosupplementation market is witnessing robust growth, propelled by the rising incidence of osteoarthritis, particularly among the elderly population. As demand for non-invasive treatments surges, viscosupplementation has become a preferred option for delaying joint replacement surgeries. Advances in hyaluronic acid formulations and a shift toward minimally invasive techniques are enhancing market adoption. The emphasis on maintaining physical mobility, coupled with an increasing elderly demographic and a rise in sports-related injuries, is further boosting market dynamics. However, challenges such as high treatment costs, reimbursement hurdles, and variability in effectiveness across different patient groups pose significant barriers to market expansion. Additionally, the presence of alternative treatments and varying regional regulations and reimbursement policies can further complicate market development in this sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Viscosupplementation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Viscosupplementation Market Segments Analysis

Global Viscosupplementation Market is segmented by Product, Application, Source, End User and region. Based on Product, the market is segmented into Introduction, Single Injection, Three Injection and Five Injection. Based on Application, the market is segmented into Introduction, Knee Osteoarthritis, Hip Osteoarthritis, Shoulder Osteoarthritis and Other Applications. Based on Source, the market is segmented into Introduction, Animal Source and Non-Animal Source. Based on End User, the market is segmented into Introduction, Hospitals, Orthopedic Clinics/Ambulatory Surgical Centers (ASCS), Retail Pharmacies and Online Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Viscosupplementation Market

A key market driver for the global viscosupplementation market is the increasing prevalence of osteoarthritis and related joint disorders among the aging population. As individuals live longer and maintain more active lifestyles, the demand for effective pain management solutions, such as viscosupplements, grows. These injectable treatments provide relief by enhancing joint lubrication and cushioning, thus improving mobility and quality of life. Additionally, rising health awareness and a shift toward minimally invasive treatment options contribute to the market's expansion, as patients and healthcare providers seek alternatives to traditional surgical interventions for joint health.

Restraints in the Global Viscosupplementation Market

One significant market restraint for the global viscosupplementation market is the increasing scrutiny and regulatory challenges associated with the approval of hyaluronic acid-based products. As healthcare authorities strengthen their standards for clinical efficacy and safety, companies face heightened pressure to demonstrate the long-term benefits of viscosupplements in treating osteoarthritis and related conditions. This rigorous approval process can lead to delays in product launches and increased costs for research and development, potentially stifling innovation and limiting the availability of new treatment options for patients. Moreover, the uncertainty surrounding reimbursement policies may hinder adoption among healthcare providers and patients alike.

Market Trends of the Global Viscosupplementation Market

The Global Viscosupplementation market is experiencing a significant shift towards single-injection and long-acting formulations, driven by the increasing preference for convenient and efficient treatment options. Patients and healthcare providers are gravitating towards single-injection hyaluronic acid therapies due to their reduced clinic time and procedural risks, enhancing patient compliance. Simultaneously, the introduction of long-acting formulations offers extended joint lubrication and pain relief, leading to improved treatment outcomes. This trend reflects broader changes in outpatient care, highlighting a cost-effective approach to managing osteoarthritis and catering to the growing demand for less invasive and more effective therapeutic solutions.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Technology Assessment

Global Viscosupplementation Market Size by Product & CAGR (2026-2033)

• Market Overview
• Introduction
• Single Injection
• Three Injection
• Five Injection

Global Viscosupplementation Market Size by Application & CAGR (2026-2033)

• Market Overview
• Introduction
• Knee Osteoarthritis
• Hip Osteoarthritis
• Shoulder Osteoarthritis
• Other Applications

Global Viscosupplementation Market Size by Source & CAGR (2026-2033)

• Market Overview
• Introduction
• Animal Source
• Non-Animal Source

Global Viscosupplementation Market Size by End User & CAGR (2026-2033)

• Market Overview
• Introduction
• Hospitals
• Orthopedic Clinics/Ambulatory Surgical Centers (ASCS)
• Retail Pharmacies
• Online Pharmacies

Global Viscosupplementation Market Size & CAGR (2026-2033)

• North America (Product, Application, Source, End User)
  • US
  • Canada
• Europe (Product, Application, Source, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, Source, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, Source, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, Source, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anika Therapeutics, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SEIKAGAKU CORPORATION (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet Holdings, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioventus Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fidia Farmaceutici S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ferring Pharmaceuticals (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avanos Medical, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LG Chem, Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBSA Institut Biochimique SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viatris Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lifecore Biomedical, LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aptissen SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chugai Pharmaceutical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kolon TissueGene, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TRB CHEMEDICA SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations